Long-term experience with Enovid among clinic patients: results after 2 and one-half to 6 years of individual patient use.
J Reprod Med
; 5(2): 90-5, 1970 Aug.
Article
em En
| MEDLINE
| ID: mdl-5521775
ABSTRACT
PIP 64 women clients of Planned Parenthood of Evansville (Indiana) used Enovid (5 mg norethynodrel and .075 mg mestranol, combined) for 2 1/2 to 6 years. A "25-Month Club" card and free pills were given to encourage continuation in the study, and 33 women (52%) remained until study termination. The group ranged in age from 18-40 years, mean 27 years, and in parity 0 to 12, mean 4. No pregnancies, cancer of reproductive organs or thromboembolism occurred. Side effects, recorded by interview according to a standard form, included cervicitis 48%, vaginal discharge 42%; dysmenorrhea 61% pretreatment, 42% improved, 11% new symptoms; breast complaints 33%; 2-15 lb weight gain 19%. 12% reported no side effects, although the author commented that the 25-Month Club policy might have discouraged reporting of side effects.^ieng
Palavras-chave
Biology; Body Weight; Central Nervous System; Central Nervous System Effects; Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Dermatological Effects; Diseases; Dysmenorrhea; Family Planning; Longitudinal Studies; Menstruation Disorders; Mestranol--side effects; Nausea; Norethynodrel--side effects; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Physiology; Research Methodology; Studies
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Anticoncepcionais Orais
/
Distúrbios Menstruais
/
Mestranol
/
Noretinodrel
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Ano de publicação:
1970
Tipo de documento:
Article